JH295

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

JH295  纯度: 99.53%

JH295 是一种有效，不可逆和选择性的 NIMA-related kinase 2 (Nek2) 抑制剂，IC50 为 770 nM。JH295 通过 Cys22 的烷基化抑制细胞 Nek2。JH295 对有丝分裂激酶 Cdk1，Aurora B 或 Plk1 没有活性，并且不会干扰双极纺锤体组件或纺锤体组件检查点。

JH295

JH295 Chemical Structure

CAS No. : 1311143-71-1

规格 价格 是否有货 数量
5 mg ￥4500 In-stock
10 mg ￥8000 In-stock
25 mg ￥15500 In-stock
50 mg ￥23500 In-stock
100 mg ￥34000 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

JH295 相关产品

•相关化合物库:

  • Bioactive Compound Library Plus

生物活性

JH295 is a potent, irreversible and selective NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 770 nM. JH295 inhibits cellular Nek2 via alkylation of Cys22. JH295 is inactive against the mitotic kinases, Cdk1, Aurora B or Plk1, and does not perturb bipolar spindle assembly or the spindle assembly checkpoint[1].

IC50 & Target

IC50: 770 nM (Nek2)[1]
体外研究
(In Vitro)

JH295 (Compound 16; 0.08-20 μM; 45 minutes; RPMI7951 cells) treatment inhibits WT Nek2 in cells with an IC50 of ~1.3 μM, whereas it has little effect on the C22V mutant[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: RPMI7951 cells
Concentration: 0.08 μM, 0.25 μM, 0.74 μM, 2.2 μM, 6.6 μM, 20 μM
Incubation Time: 45 minutes
Result: Inhibited WT Nek2 in cells with an IC50 of ~1.3 μM, whereas had little effect on the C22V mutant.

分子量

320.35

Formula

C18H16N4O2
CAS 号

1311143-71-1
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

-20°C, stored under nitrogen

*该产品在溶液状态不稳定，建议您现用现配，即刻使用。
溶解性数据
In Vitro: 

DMSO : 55 mg/mL (171.69 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.1216 mL 15.6079 mL 31.2159 mL
5 mM 0.6243 mL 3.1216 mL 6.2432 mL
10 mM 0.3122 mL 1.5608 mL 3.1216 mL

*

请根据产品在不同溶剂中的溶解度，选择合适的溶剂配制储备液；该产品在溶液状态不稳定，建议您现用现配，即刻使用。
参考文献

  • [1]. Jeffrey C Henise, et al. Irreversible Nek2 kinase inhibitors with cellular activity. J Med Chem. 2011 Jun 23;54(12):4133-46.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务